Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds CJS Securities Downgrades Unisys to Market Perform

CJS Securities Downgrades Unisys to Market Perform

CJS Securities analyst Jonathan Tanwanteng downgrades Unisys (NYSE:UIS) from Market Outperform to Market Perform.

byBenzinga Newsdesk

November 9, 2022

1 minute read

CJS Securities analyst Jonathan Tanwanteng downgrades Unisys (NYSE:UIS) from Market Outperform to Market Perform.

89bio Outlines Roadmap For Pivotal Studies For Lead Program In Fatty Liver Disease

By Vandana Singh

December 4, 12:38 PM

89bio Inc (NASDAQ: ETNB) announced a successful end-of-Phase 2 Meeting with the FDA supporting the advancement of pegozafermin into Phase 3 in

ETNB

Akoustis Technologies’ Q1 Misses Expectations, Sees Record Q4 Revenue

By Anusuya Lahiri

May 8, 8:11 AM

Akoustis Technologies, Inc (NASDAQ:AKTS) reported third-quarter FY23 revenue growth of 59.7% year-on-year to $7.36 million, missing the consensus of $7.53…

AKTS

Wedbush Maintains Outperform on Amazon.com, Lowers Price Target to $140

By Benzinga Newsdesk

October 28, 9:10 AM

Wedbush analyst Michael Pachter maintains Amazon.com (NASDAQ:AMZN) with a Outperform and lowers the price target from $175 to $140.

AMZN

Why Salesforce Stock Is Moving Higher Thursday

By Adam Eckert

August 31, 8:35 AM

Salesforce Inc (NYSE: CRM) shares are trading higher Thursday after the company reported better-than-expected quarterly results and issued strong guidance.

CRM

CJS Securities Downgrades Unisys to Market Perform

Related Posts

89bio Outlines Roadmap For Pivotal Studies For Lead Program In Fatty Liver Disease

Akoustis Technologies’ Q1 Misses Expectations, Sees Record Q4 Revenue

Wedbush Maintains Outperform on Amazon.com, Lowers Price Target to $140

Why Salesforce Stock Is Moving Higher Thursday